Skip to content

Steroid infusion using a spray tube after ESD for esophageal cancer

A randomized controlled trial of steroid infusion using a spray tube after ESD for esophageal cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1061220099
Enrollment
100
Registered
2023-02-23
Start date
2022-10-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

As a technical intervention, steroid infusion using a spraying tube or local steroid injection using a local injection needle is performed for postoperative esophageal ulcers immediately after ESD.

Sponsors

Goto Atsushi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with esophageal cancer or suspected esophageal cancer by endoscopy and biopsy 2. Esophageal cancer is diagnosed as confined to submucosal infiltration by preoperative endoscopic diagnosis. 3. Patients who are expected to undergo esophageal ESD for esophageal cancer and resection of 3/4 or more of the luminal circumference but less than the entire circumference 4. Written consent has been obtained from the patient or legally acceptable representative after receiving a sufficient explanation about study participation.

Exclusion criteria

Exclusion criteria: (1) Patients with esophageal cancer whose major axis exceeds 5 cm (2) Patients taking steroids before esophageal ESD (3) Patients judged by the researcher's doctor to be inappropriate for this study

Design outcomes

Primary

MeasureTime frame
Primary endpoint: stenosis rate in the spraying tube group and needle group

Secondary

MeasureTime frame
Secondary endpoints: rate of adverse events, number of endoscopic balloon dilatations

Contacts

Public ContactAtsushi Goto

Yamaguchi University Hospital

agoto@yamaguchi-u.ac.jp+81-836222241

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026